CD274 and hepatocellular carcinoma: Therefore, the continued characterization of the novel connection between inflammation and tumor immune evasion and identification of crucial inflammatory events with PD-L1 expression in HCC would provide additional targets for improving the clinical responses with immune checkpoint blockade therapies.